Curated News
By: NewsRamp Editorial Staff
June 09, 2025
Nutriband Secures U.S. Patent for Abuse-Deterrent Transdermal Technology
TLDR
- Nutriband's new U.S. patent for its Aversa technology offers a competitive edge in the abuse-deterrent transdermal market, potentially capturing significant sales with Aversa Fentanyl.
- The U.S. patent No. 12,318,492 details Nutriband's method to prevent abuse and misuse in transdermal systems, enhancing its Aversa technology's market protection.
- Nutriband's Aversa technology aims to reduce drug abuse and accidental exposure, contributing to safer medication practices and better public health outcomes.
- Discover how Nutriband's patented Aversa technology is revolutionizing transdermal patches to combat drug abuse, with Aversa Fentanyl leading the charge.
Impact - Why it Matters
This development is crucial as it represents a significant advancement in the fight against opioid abuse, a major public health crisis. Nutriband's Aversa(TM) technology offers a promising solution to reduce the misuse and accidental exposure to potent drugs like fentanyl, potentially saving lives and reducing healthcare costs associated with drug abuse.
Summary
Nutriband Inc. (NASDAQ: NTRB) has achieved a significant milestone with the granting of U.S. patent No. 12,318,492 for its innovative 'Abuse and Misuse Deterrent Transdermal Systems.' This patent, awarded on June 3, 2025, bolsters the company's intellectual property rights for its Aversa(TM) technology, a groundbreaking approach designed to combat the abuse, misuse, diversion, and accidental exposure of drugs with high abuse potential. At the heart of Nutriband's development pipeline is Aversa Fentanyl, poised to become the first abuse-deterrent fentanyl patch in the market, with projected U.S. sales ranging between $80 million and $200 million. For more details, visit the full article.
Nutriband Inc. is at the forefront of transdermal pharmaceutical innovation, focusing on enhancing drug safety through its proprietary AVERSA(TM) technology. This technology is adaptable to any transdermal patch, offering a versatile solution to a pressing public health issue. Discover more about their pioneering work at www.Nutriband.com.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Nutriband Secures U.S. Patent for Abuse-Deterrent Transdermal Technology
